Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as soblidotin use different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of soblidotin in treating patients who
have progressive locally advanced or metastatic non-small cell lung cancer.